EMFIB 250MG TABLET
₹2526.42*
MRP ₹3081
18% off
₹2619*
MRP ₹3081
15% CB
₹462 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
EMFIB 250MG TABLET belongs to the group of medicine called ‘anti-cancer’, primarily indicated in lung cancer treatment. Lung cancer is the uncontrolled growth of abnormal cells in one or both lungs. These abnormal cells do not carry out normal lung cell functions and do not develop into healthy lung tissue. In this disease, cells of the lung grow uncontrollably, and if not detected at an early stage may spread to other body parts, including the brain.
EMFIB 250MG TABLET contains 'Gefitinib' which belongs to the group of medicines known as 'kinase inhibitors'. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells.
Take EMFIB 250MG TABLET as prescribed by your doctor. You are suggested to take EMFIB 250MG TABLET as long as your doctor has prescribed it after checking your medical condition. In some cases, you may experience certain common side effects such as itching or skin rash, acne, nail problems, vomiting, diarrhea, and loss of appetite. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
To treat your condition effectually, continue taking EMFIB 250MG TABLET for as long as your doctor has prescribed. Do not take EMFIB 250MG TABLET if you are pregnant or planning for pregnancy as EMFIB 250MG TABLET causes serious birth defects. EMFIB 250MG TABLET should not be taken by breastfeeding mothers as it passes into breast milk and may cause a possible risk to the infant. Elderly people are more sensitive to medicine so they may adjust the dosage according to their condition. Avoid consuming alcohol along with EMFIB 250MG TABLET as it could lead to increased dizziness.
EMFIB 250MG TABLET is indicated to the patients dealing with non-small cell lung cancer. Cancer of this type tends to spread quickly in other parts of the body. EMFIB 250MG TABLET travels through the bloodstream and effectively destroys cancerous cells of the lung and other parts of the body. EMFIB 250MG TABLET is a ' tyrosine kinase inhibitor (TKI)', that stops the uncontrolled growth and spread of cancerous cells. It acts by stopping the abnormal protein action that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed, it undergoes a usual process of maturity. Cancerous cells form new cells more quickly, so EMFIB 250MG TABLET targets cancerous cells and blocks the action of Tyrosine kinase enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, EMFIB 250MG TABLET stops the production, spread and growth of cancerous cells in the body.
Tell your doctor if you have liver or kidney disease, vision problems, breathing problems or taking any blood thinner like warfarin. Before undergoing any surgery, it is advised to tell the medical professional who performs the procedure about all the medicines you are taking. Some persons may experience diarrhoea as a side effect of EMFIB 250MG TABLET, so it is advised to drink a lot of water and tell your doctor in such a case. Inform your doctor if you notice any severe side effects of EMFIB 250MG TABLET, including shortness of breath, worsening cough, and other vision problems. You need to go to regular blood tests to check if this medicine is working fine for you. Avoid high-fibre foods, raw fruits, cereals, vegetables, and drink lots of water as EMFIB 250MG TABLET may cause diarrhoea.
Drug-Drug Interaction: EMFIB 250MG TABLET may have interaction with other anti-cancer medicine (Sorafenib and Paclitaxel), antibiotics (Neomycin), anti-seizure medicine (carbamazepine, phenytoin), NSAIDs (ibuprofen, naproxen), blood thinners (warfarin) and an antacid (Omeprazole).
Drug-Food Interaction: Avoid high-fiber foods, raw fruits, cereals, and vegetables, and drink lots of water as EMFIB 250MG TABLET may cause diarrhoea.
Drug-Disease Interaction: Tell your doctor if you have liver or kidney disease, vision problems, breathing problems.
Lung cancer: It happens when cells in the lung begin to grow in an uncontrolled manner. The most common form of lung cancer is non-small cell lung cancer (NSCLC). It happens when cells that form the lining of the lung start growing uncontrollably. Persons who smoke are at high risk of lung cancer. A common symptom of NSCLC is a cough that does not go easily followed by shortness of breath. Cancerous cells of the lung spread off and travel through the bloodstream to distant regions of the body and grow.
Country of origin
Manufacturer/Marketer address
Alcohol
Unsafe
You are recommended to avoid alcohol consumption with EMFIB 250MG TABLET as it may increase the risk of side effects such as dizziness, drowsiness, or difficulty in concentrating.
Pregnancy
Unsafe
EMFIB 250MG TABLET is restricted to use in pregnancy. A woman needs to have a negative pregnancy test before starting treatment with this medicine. It is better to use effective birth control methods to prevent pregnancy while taking this medicine or at least 6 months after taking the last dose of EMFIB 250MG TABLET.
Breast Feeding
Unsafe
EMFIB 250MG TABLET should not be taken by breastfeeding mothers as it passes into breast milk and may cause a possible risk to the infant.
Driving
Caution
It is not known if EMFIB 250MG TABLET may affect your driving ability or not. Drive only if you are physically stable and mentally focussed. If you experience drowsiness after taking this medication, you should not drive or operate any machinery or vehicles.
Liver
Caution
EMFIB 250MG TABLET should be taken with caution in patients dealing with liver disease. The doctor may adjust the dose according to the medical condition of the patient.
Kidney
Caution
EMFIB 250MG TABLET is safe to take by patients dealing with kidney disease as prescribed by their doctor. The doctor may adjust the dose according to the medical condition of the patient.
Children
Unsafe
EMFIB 250MG TABLET is not recommended for children below 18 years as the safety and effectiveness were not established.
Product Substitutes